Skip to content
10-K

Annual Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-21-002564

← back to feed
Filed
Oct 14, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Sep 15, 2021 7.75M sh
Operating Cash Flow FY 2021 · Jun 30, 2021 $0
Operating Cash Flow FY 2021 · Jun 30, 2020 $0
Long Term Debt FY 2021 · Jun 30, 2021 $0
Long Term Debt FY 2021 · Jun 30, 2020 $0
Cash And Equivalents FY 2021 · Jun 30, 2021 $0
Cash And Equivalents FY 2021 · Jun 30, 2020 $0
Cash And Equivalents FY 2021 · Jun 30, 2019 $0
Stockholders Equity FY 2021 · Jun 30, 2021 −$503.21K
Stockholders Equity FY 2021 · Jun 30, 2020 −$396.67K
Stockholders Equity FY 2021 · Jun 30, 2019 −$332.29K
Current Liabilities FY 2021 · Jun 30, 2021 $503.21K
Current Liabilities FY 2021 · Jun 30, 2020 $396.67K
Total Liabilities FY 2021 · Jun 30, 2021 $503.21K
Total Liabilities FY 2021 · Jun 30, 2020 $396.67K
Current Assets FY 2021 · Jun 30, 2021 $0
Current Assets FY 2021 · Jun 30, 2020 $0
Total Assets FY 2021 · Jun 30, 2021 $0
Total Assets FY 2021 · Jun 30, 2020 $0
Sga Expense FY 2021 · Jun 30, 2021 $851
Sga Expense FY 2021 · Jun 30, 2020 $0
Net Income FY 2021 · Jun 30, 2021 −$106.54K
Net Income FY 2021 · Jun 30, 2020 −$122.05K
Operating Income FY 2021 · Jun 30, 2021 −$45.37K
Operating Income FY 2021 · Jun 30, 2020 −$33.06K
Revenue FY 2021 · Jun 30, 2021 $0
Revenue FY 2021 · Jun 30, 2020 $0